Tech Company Financing Transactions
VitalConnect Funding Round
On 5/24/2017, VitalConnect landed $38 million in Series C funding from Baxter Ventures, MVM Life Science Partners and private investors.
Transaction Overview
Company Name
Announced On
5/24/2017
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series C
Investors
Baxter Ventures (Lead Investor) (Anne Sissel)
MVM Life Science Partners (Lead Investor) (Stephen Reeders)
Proceeds Purpose
This funding round will be used to further commercialize the VitalConnect Platform and make significant strides in changing the way patient monitoring is utilized in hospitals and at home.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
224 Airport Pkwy. 300
San Jose, CA 95110
USA
San Jose, CA 95110
USA
Phone
Website
Email Address
Overview
Headquartered in the heart of Silicon Valley, California, VitalConnect was founded in 2011 with a vision of changing the paradigm of healthcare as we know it by creating a new world of information with predictive data analytics at everyone's fingertips.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nersi Nazari
Chief Medical Officer
Joseph Roberson
VP - Human Resources
Allison Herd
VP - Product Management
Ian Felix
Browse more venture capital transactions:
Prev: 5/24/2017: Frichti venture capital transaction
Next: 5/24/2017: StaffConnect Group venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs